ATLANTA, June 06, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ:MRNS). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company's business, operations, and prospects, including allegations that: (1) Defendants understated the risk of failure to meet the early-stopping criteria in the RAISE trial; and (2) Defendants did not disclose that a possible consequence of failing to meet the early stopping criteria in the RAISE ...
MRNS) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm>Full story available on Benzinga.com